Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
Israel Ministry of Foreign Affairs - Premier Kathleen Wynne visited Teva Pharmaceutical Industries Ltd., where she met with Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer. Israeli Teva is
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Teva Goes High Tech to Deliver Medicine Through Implanted Microchip | Messianic Bible
Michael Hayden - News, Articles, Whitepapers - Drug Target Review
Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva In Transition: Generics, Specialty And 'The Space Between' :: Scrip
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Meet the Investigator – HD Insights
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Teva and Microchips : Partnership through Digital Drug Delivery Technology. Opening of Teva R&D Center in Croatia - Israël Science Info
ABOUT US | Prilenia Therapeutics
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
DEF 14A
VIP Reception
Michael Hayden - Director at n-Lorem Foundation | The Org
Teva CEO promises to reshape, refocus company | Reuters
Axovant poaches Allergan's and Teva's chief medical and science officers - PMLiVE
Michael Hayden - News, Articles, Whitepapers - Drug Target Review
Teva appoints genetics specialist as its first president of global R&D - PMLiVE
Michael Hayden - Principal @ Chertoff Group - Recent News and Activity
